L.M. Kohn & Company Moderna, Inc. Transaction History

L.M. Kohn & Company

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$118.38 - $210.04 $168,809 - $299,517	1,426 New	1,426 $256,000
Q2 2022 Aug 05, 2022	SELL	$117.13 - $176.59 $16,281 - $24,546	-139 Reduced 7.62%	1,686 $241,000
Q1 2022 May 25, 2022	BUY	$126.46 - $235.05 $230,789 - $428,966	1,825 New	1,825 $315,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of L.M. Kohn & Company, based on Form 13F filings with the SEC.

Stay updated on L.M. Kohn & Company with notifications on news.